An oncolytic vesicular stomatitis virus (VSV)-based therapy designed to selectively infect and kill cancer cells, used alone or combined with immuno-oncology drugs in clinical trials for multiple cancer types.

A measles virus-based oncolytic therapy encoding the human sodium iodide symporter (NIS) gene, designed to target and kill cancer cells, currently in clinical trials for bladder cancer and brain tumors.